Michael Hacala

Senior Shock Field Research Specialist at J&J MedTech / Abiomed. Former #NCSI & #CERAMICS Coordinator @ Henry Ford Health. #NationalCSI #cardiogenicshock #AMICS

[Babar Basir @Babar_Basir]

The problem: AMI-CS associated with significant morbidity & mortality w/o much change in >20 yrs

NCSI is a single arm, multi-center study evaluating the feasibility & effectiveness of using early MCS w Impella in AMI-CS.

Importantly we included large community programs!

[Babar Basir @Babar_Basir]

Final results of NCSI published!

Early Utilization of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The National Cardiogenic Shock Initiative | Journal of the American Heart Association https://t.co/pcOxTCiZEL

[Chuck Simonton @DrChuckSimonton]

Really enjoyed being with the GWU team in D.C. discussing the STEMI DTU RCT and their experience enrolling in the trial. Great group of cardiologists, intensivists, surgeons, fellows and research coordinators with a passion for this study. @NavinKapur4 @BillONeillMD @GreggWStone

[Navin Kapur @NavinKapur4]

Thrilled to announce the launch of #STEMI-DTU in Canada. Grateful to @SanjitSJolly @DrChuckSimonton @Abiomed for leading the effort across Canada. Now to ski the backside of this enrollment mountain! Came back to Boston just in time to enroll @TuftsMedicalCtr @TuftsMCResearch

[Alex Truesdell @agtruesdell]

1/4 “Optimal Large-Bore Femoral Access, Indwelling Device Management, and Vascular Closure for Percutaneous Mechanical Circulatory Support” in @AmJCardio: (“soup to nuts”, operator-focused, and “real world”) led by @yadersandoval👍: https://t.co/qKJvCgxMl6 …

[Navin Kapur @NavinKapur4]

Honored to connect with #DTU Operators and Teams from NJ and to meet a Thriving DTU patient of @HaroonFarazMD Let’s increase awareness of the devastating effect of #reperfusioninjury in STEMI and #unload to reduce the burden of post-MI #heart failure & achieve recovery @Abiomed

[Aditya Mehra @Aditya_Mehra02]

Never gets old. Listening to @NavinKapur4 talking about LV unloading and #dtustemi study.
@vandanMD @HaroonFarazMD @rzakir12 @Mike_Hacala @Abiomed @HMHNewJersey @HMHSchoolofMed ❤️

[Babar Basir @Babar_Basir]

Congratulations to Jacob Muller, and the entire DanGer Shock team on completing the 360 pt trial in CS. Challenging trial, that took 10 years and the whole MCS space has changed in that time, but important trial that along with ECLS-shock and Recover IV will shape this field

[Babar Basir @Babar_Basir]

Shock teams workshop is now open for registration. Thinking about starting a shock team, want to organize shock care in your hospital. Please considering signing your team up at the link below … https://t.co/cmCdgpO2AC

[herbaronowMD @herbaronowMD]

Congrats @Babar_Basir & @PedroMDMSc on winning @SCAI 30 in Their 30s awards, recognizing ‘early-career interventionalists who epitomize the qualities expected of future leaders in interventional cardiology.’ We are lucky to have you at @HenryFordHealth @HFHCardioFellow !

[Babar Basir @Babar_Basir]

Who is ready for a jam packed 3 days discussing CS, program building, MCS and most importantly hanging out with like minded CS enthusiasts & friends! @PerwaizMeraj @Allison_Dupont @SrihariNaiduMD @agtruesdell @NavinKapur4 @JasonKatzMD @HenrytTimothy @preventfailure @CardioNerds

[Seth Bilazarian, MD @DrSethdb]

Terrific talk #ACC2023
Impact of #ShockTeams on patient outcomes by Shock Team faculty @TriStarHealth in Nashville. @AnnGageMD lead a great case discussion recounting the management decisions resulting from collaboration between interventional cardiology, surgery & heart failure

[Brian Kolski,MD @bkolskk]

My sons 6th science project describes cardiogenic shock - love it!! 🍎 🌲 #NCSI #cardiogenicshock #systemshutdown

[Navin Kapur @NavinKapur4]

Excited to be part of the future of transvalvular ventricular #unloading with the #Impella #ECP from @Abiomed First and only center in New England to offer this 9Fr #innovation for complex #PCI to our patients and IC/HF Fellows @TuftsMedicalCtr Single Angioseal on the way out!

[Seth Bilazarian, MD @DrSethdb]

FIRST CASES OF THE ABIOMED PIVOTAL IMPELLA ECP STUDY....

@Ascensionorg St. John in Detroit, with @DrAmirKaki
Fantastic ECP device performance: easy AoV crossing, LV position optimized, high pump flows & excellent hemodynamic support during 2 unprotected left main Protected PCI

[Babar Basir @Babar_Basir]

Congratulations to @DrTedSchreiber @DrAmirKaki @tlalondemd for the first enrollment into the CERAMICS trial at St Johns Hospital in Detroit!! What are the outcomes of consecutive AMI-CS patients treated at sites with MCS escalation capabilities! @BillONeillMD @Mike_Hacala

[Babar Basir @Babar_Basir]

Join us next week to discuss up to date STEMI care!! If you don’t come for the content come for the location 😜! @HFHCardioFellow @DBCardsFellows @BeaumontIC @BeaumontCards @AscensionM_CV @APH_CV_Fellows @MichiganACC

[Babar Basir @Babar_Basir]

Really excited to expand #ISOSHOCK to stage B and pts treated with medications, iabp or impella for shocked. Randomized based on level of support and SSO2 therapy vs control

[Timothy Smith, MD @TimDSmithMD]

Hope folks can make this conference as it will be amazing!

[Babar Basir @Babar_Basir]

We honestly can get AMI-CS mortality to <10% in the next 10-20 yrs. This should be our generations goal. In the same way our contemporaries have for STEMI and AS/TAVR! 100% believe this is achievable!! We have a reliable way of treating AMI-CS #NCSI #shockprotocol #shockteam #mcs